Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
beta-Cell death during progression to diabetes
Government healthcare policies and regulations regarding drug pricing and reimbursement play a critical role in determining the affordability and market penetration of GLP-1 receptor agonists
Bimagrumab is a first-in-class, fully humanized monoclonal antibody developed by Versanis Bio, a clinical-stage biopharmaceutical company recently acquired by Eli Lilly
When paired with dietary adjustments and increased physical activity, the benefits become even more pronounced
US$ 27.18
US$ 27.43
US$ 20.50
US$ 21.07
US$ 28.14
